Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janakiraman Subramanian

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|July 5, 2008
Molecular genetics of lung cancer in people who have never smokedJanakiraman Subramanian, Ramaswamy Govindan
The Lancet. Oncology|January 31, 2012
Optimising therapy for EGFR-addicted NSCLC: just the startRamaswamy Govindan, Janakiraman Subramanian
Translational Lung Cancer Research|September 11, 2023
Telisotuzumab vedotin with erlotinib in the treatment of non-small cell lung cancer: a well MET combination?Lara Kujtan, Janakiraman Subramanian
Expert Review of Anticancer Therapy|May 7, 2021
Detection of <i>MET</i> exon 14 skipping mutations in non-small cell lung cancer: overview and community perspectiveJanakiraman Subramanian, Ossama Tawfik
Oncology (Williston Park, N.Y.)|March 2, 2010
Lung cancer in 'Never-smokers': a unique entityJanakiraman Subramanian, Ramaswamy Govindan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Lung cancer in never smokers: a reviewJanakiraman Subramanian, Ramaswamy Govindan
Expert Review of Anticancer Therapy|March 28, 2019
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancerLara Kujtan, Janakiraman Subramanian
Clinical Lung Cancer|October 1, 2008
Small cell, big problem! Stem cells, root cause?Janakiraman Subramanian, Ramaswamy Govindan
Nature Reviews. Clinical Oncology|February 2, 2010
Chemotherapy: continued lack of progress in SCLCJanakiraman Subramanian, Ramaswamy Govindan
Frontiers in Oncology|January 15, 2024
Treating patients with platinum-sensitive extensive-stage small-cell lung cancer in a real-world settingJacob Sands, Janakiraman Subramanian
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|July 5, 2008
Molecular genetics of lung cancer in people who have never smokedJanakiraman Subramanian, Ramaswamy Govindan
The Lancet. Oncology|January 31, 2012
Optimising therapy for EGFR-addicted NSCLC: just the startRamaswamy Govindan, Janakiraman Subramanian
Translational Lung Cancer Research|September 11, 2023
Telisotuzumab vedotin with erlotinib in the treatment of non-small cell lung cancer: a well MET combination?Lara Kujtan, Janakiraman Subramanian
Expert Review of Anticancer Therapy|May 7, 2021
Detection of <i>MET</i> exon 14 skipping mutations in non-small cell lung cancer: overview and community perspectiveJanakiraman Subramanian, Ossama Tawfik
Oncology (Williston Park, N.Y.)|March 2, 2010
Lung cancer in 'Never-smokers': a unique entityJanakiraman Subramanian, Ramaswamy Govindan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Lung cancer in never smokers: a reviewJanakiraman Subramanian, Ramaswamy Govindan
Expert Review of Anticancer Therapy|March 28, 2019
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancerLara Kujtan, Janakiraman Subramanian
Clinical Lung Cancer|October 1, 2008
Small cell, big problem! Stem cells, root cause?Janakiraman Subramanian, Ramaswamy Govindan
Nature Reviews. Clinical Oncology|February 2, 2010
Chemotherapy: continued lack of progress in SCLCJanakiraman Subramanian, Ramaswamy Govindan
Frontiers in Oncology|January 15, 2024
Treating patients with platinum-sensitive extensive-stage small-cell lung cancer in a real-world settingJacob Sands, Janakiraman Subramanian
Pageof 9